AzTrials
AzTrials

Developmental Coordination Disorder (DCD)Climbing TDCNCT07609563

Therapeutic Climbing for Children With DCD

A study testing CO-OP-based group therapeutic climbing intervention in people with Developmental Coordination Disorder (DCD), run by Université de Sherbrooke.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study looks at whether therapeutic climbing - indoor climbing activities guided by therapists - can help children with Developmental Coordination Disorder (DCD). DCD is a condition where children have difficulty with motor skills and participation in everyday activities, and sometimes confidence in physical… Read more about this study

Who is it for?
Ages 8 to 12 years
What is being tested?
CO-OP-based group therapeutic climbing intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
No sites listed yet
Study dates
15 May 2026to 6 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosis of DCD by a physician*.
  • Ability to follow instructions, communicate verbally, interact with adults and peers, and use cognitive strategies.
  • Ability to attend all assessment and intervention sessions in Sherbrooke.
  • Ability to understand and speak French.
  • Provision of child assent and parental consent. * If the target sample size (n = 16) is not reached, children with suspected DCD based on the Developmental Coordination Disorder Questionnaire (DCDQ) (25,26) will also be considered. Eligibility will then require: (1) a score below the 15th percentile on the total motor composite or below the 5th percentile in a domain of the Bruininks-Oseretsky Test of Motor Proficiency (BOT) (27,28), and (2) the identification of occupational challenges using the Canadian Occupational Performance Measure (COPM) (29,30) during the initial assessment.

Who cannot join

  • Diagnosis of severe behavioral disorders, autism spectrum disorder, intellectual disability, cerebral palsy, muscular dystrophy, and/or severe functional limitations.
  • Prior proficiency in climbing or absence of climbing-related goals.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Emmanuelle Jasmin, Ph.D. contact

1-819-342-0305

emmanuelle.jasmin@usherbrooke.ca

About this study

Official title: Therapeutic Group Climbing for Children With Developmental Coordination Disorder: Randomized Crossover Trial

This study looks at whether therapeutic climbing - indoor climbing activities guided by therapists - can help children with Developmental Coordination Disorder (DCD).

DCD is a condition where children have difficulty with motor skills and participation in everyday activities, and sometimes confidence in physical activities.

The climbing program is based on a problem-solving approach called CO-OP (Cognitive Orientation to daily Occupational Performance), in which children learn strategies to achieve goals.

Read the detailed description

Background: Therapeutic climbing, based on the Cognitive Orientation to daily Occupational Performance (CO-OP) approach, may improve goal performance and satisfaction in children with Developmental Coordination Disorder (DCD), as well as their motivation and self-efficacy toward physical activity.

Objective: This study aims to examine the effectiveness of a CO-OP-based group therapeutic climbing intervention for children with DCD.

Methods: A randomized crossover trial will be conducted with children with DCD. The intervention will consist of a 10-week group-based therapeutic climbing program delivered in an indoor climbing setting. Primary outcomes will include performance and satisfaction related to individualized goals. Secondary outcomes will assess motor skills, self-efficacy, executive functions, motivation toward physical activity, and transfer of learning. Effects of the intervention will be assessed using linear mixed effects models.

Results: It is hypothesized that participants will demonstrate improvements in both primary and secondary outcomes following the intervention.

Conclusions: This study will contribute to the evidence base regarding therapeutic climbing and CO-OP-based interventions for children with DCD, informing future rehabilitation practices.

Being tested
CO-OP-based group therapeutic climbing intervention
Keywords
Therapeutic climbing, Neurodevelopmental condition, Group intervention, Participation-oriented approach, Occupational therapy
Medical subject headings
Motor Skills Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CO-OP-based group therapeutic climbing interventionOther

    The intervention will consist of a 10-week group-based therapeutic climbing program delivered once weekly on Saturday afternoons at an indoor climbing center. Sessions will be delivered by an occupational therapist (OT), two occupational therapy interns, and a certified climbing monitor (hereafter referred to as "intervention providers"). Each 90-minute session will follow the same global structure. The intervention is grounded in the CO-OP approach.

Study groups in NCT07609563
Study groupRoleWhat they receive
Group 1 - Fall 2026ExperimentalFirst group intervention
Receives: Other: CO-OP-based group therapeutic climbing intervention
Group 2 - Winter 2027ExperimentalSecond group intervention
Receives: Other: CO-OP-based group therapeutic climbing intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance related to individualized goals

    Assess with the Canadian Occupational Performance Measure (COPM) (visual analog scale of 1-10)

    Measured: Baseline (2-3 months before the intevention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

  2. Satisfaction related to individualized goals

    Assess with the Canadian Occupational Performance Measure (COPM) (visual analog scale of 1-10)

    Measured: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

  3. Performance related to climbing-specific goals

    Assess with the Performance Quality Rating Scale (PQRS) (visual analog scale of 1-10)

    Measured: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

Secondary outcomes (4)
  1. Motor skills

    Bruininks-Oseretsky Test of Motor Proficiency, Third Edition (BOT-3) (standard scores (mean = 50, SD = 10) or scale scores for subtests (mean = 10, SD = 3))

    Measured: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

  2. Self-efficacy

    Assess with the French adaptation of the General Self-Efficacy Scale (GSES) (5-point Likert scale)

    Measured: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

  3. Executive functioning

    Assess with the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) T-scores (mean = 50, SD = 10)

    Measured: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

  4. Motivation for physical activity

    Assess with the Pictorial Motivation Scale (PMS) for physical activity (3-point scale)

    Measured: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2026
  2. Study start15 May 2026 (estimated)
  3. Primary completion6 Jun 2026 (estimated)
  4. Study completion6 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07609563
Sponsor's protocol ID
2026-6195
Other IDs
Mental health 2025-2026
Acronym
Climbing TDC
Status last verified
May 2026
First submitted
12 May 2026
Last updated
1 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CO-OP-based group therapeutic climbing intervention in people with Developmental Coordination Disorder (DCD), run by Université de Sherbrooke.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emmanuelle Jasmin, Ph.D. (1-819-342-0305, emmanuelle.jasmin@usherbrooke.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance related to individualized goals (time frame: Baseline (2-3 months before the intevention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in